Evaluation of clinical interventions made by pharmacists in chemotherapy preparation
By: Lea Knez, Raisa Laaksonen and Catherine Duggan
Open Access
|Sep 2010References
- Phillips J, Beam S, Brinker A, Holquist C, Honig P, Lee LY, et al. Retrospective analysis of mortalities associated with medication errors.2001;1835-41.
- Ocvirk J, Boc M, Rebersek M, Ros T. Cisplatin-induced non-convulsive posterior reversible encephalopathy syndrome in a 41-year-old woman with metastatic malignant melanoma.2009;120-5.
- Department of Health.. London: HMSO; 2001.
- Goldspiel BR, DeChristoforo R, Daniels CE. A continuous-improvement approach for reducing the number of chemotherapy-related medication errors.2000;S4-9.
- Mort D, Lansdown M, Smith N, Protopapa K, Mason M.London: National Confidential Enquiry into Patient Outcome and Death; 2008.
- North East London Cancer Network NHS.. London: Department of Health Publications; 2005.
- German Society of Oncology Pharmacy.. 4Edition. Oldenburg: Onko-press; 2003.
- Adams V, Blake D, Corlett S, Godward D, Low J, McMurray A, et al. Competency Framework for Specialist Oncology Pharmacists., 2004.
- Markert A, Thierry V, Kleber M, Behrens M, Engelhardt M. Chemotherapy safety and severe adverse events in cancer patients: strategies to efficiently avoid chemotherapy errors in in- and outpatient treatment.2009;722-8.
- Jaehde U, Liekwig A, Simons S, Westfeld M. Minimising treatment-associated risks in systemic cancer therapy.2008;161-8.
- Slama C, Jerome J, Jacquot C, Bonan B. Prescription errors with cytotoxic drugs and inadequacy of existing classifications.2005;339-43.
- Liekweg A, Westfeld M, Jaehde U. From oncology pharmacy to pharmaceutical care: new contributions to multidisciplinary cancer care.2004;73-9.
- Debevec L, Jerič T, Kovač V, Bitenc M, Sok M: Is there any progress in routine management of lung cancer patients? A comparative analysis of an institution in 1996 and 2006.2009;47-53.
- Knez L, Laaksonen R, Duggan C, Nijjar R. Evaluation of clinical interventions made by pharmacists in cancer services.2008;277-80.
- Burtonwood AM, Hinchliffe AL, Tinkler GG. A prescription for quality: a role for the clinical pharmacist in general practice.1998;678-80.
- Eadon H. Assessing the quality of ward pharmacists' interventions.1992;145-7.
- Price RN, Rogers A. Intervention monitoring on admissions wards.2000;81-4.
- Barber N, Batty R, Ridout DA. Predicting the rate of physician-accepted interventions by hospital pharmacists in the United Kingdom.1997;397-405.
- Hawkey CJ, Hodgon S, Norman A, Daneshmend TK, Garner ST. Effect of reactive pharmacy intervention on quality of hospital prescribing.1990;986-990.
- Allan EL, Barker KN. Fundamentals of medication error research.1990;555-71.
- Bowling A.. Philadelphia: Open University Press; 2002.
- Macintyre J, Dalrymple H, MacLean F, Lannigan N, Hudson S. Development of a system for reporting pharmaceutical care issues in cancer patients receiving chemotherapy.2003;266-7.
- Limat S, Drouhin JP, Demesmay K, Tissot E, Jacquet M, Woronoff-Lemsi MC. Incidence and risk factors of preparation errors in centralized cytotoxic preparation unit.2001;102-6.
- Bourret JA, Demeres RF, Wordell D, Irani M, Baker J, Evangelista C. Medication use review process and information systems utilized for oncology chemotherapy quality improvement.1996;1-17.
- Barber N, Cornford T, Klecun E. Qualitative evaluation of an electronic prescribing and administration system.2007;271-8.
- Nebeker JR, Hoffman JM, Weir CR, Bennett CL, Hurdle JF. High rates of adverse drug events in a highly computerized hospital.2005;1111-6.
Language: English
Page range: 249 - 256
Published on: Sep 22, 2010
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2010 Lea Knez, Raisa Laaksonen, Catherine Duggan, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.